Zhi Xie
- Oncology top 1%
- Cancer Immunotherapy and Biomarkers 17
- Cancer Research top 1%
- Cancer Genomics and Diagnostics 15
- Molecular Biology top 1%
- Gut microbiota and health 43
- RNA modifications and cancer 23
- RNA and protein synthesis mechanisms 21
- Metabolomics and Mass Spectrometry Studies 18
- Ginseng Biological Effects and Applications 16
- Pharmacology top 0.5%
-
- Lung Cancer Treatments and Mutations 38
- Partner nations
- ChinaUnited StatesHong Kong
In The Last Decade
Zhi Xie
360 papers receiving 10.5k citations
Hit Papers
Peers
Comparison fields: 5 of 188
- Oncology 2.5k
- Cancer Research 1.2k
- Molecular Biology 5.3k
- Pharmacology 581
- Pulmonary and Respiratory Medicine 2.1k
Countries citing papers authored by Zhi Xie
This map shows the geographic impact of Zhi Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhi Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhi Xie more than expected).
Fields of papers citing papers by Zhi Xie
This network shows the impact of papers produced by Zhi Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhi Xie. The network helps show where Zhi Xie may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Zhi Xie, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 2 | |
| 3 | 2025 | 0 | |
| 4 | 2025 | 0 | |
| 5 | 2025 | 0 | |
| 6 | 2025 | 3 | |
| 7 | 2024 | 0 | |
| 8 | 2024 | 3 | |
| 9 | 2024 | 6 | |
| 10 | 2024 | 7 | |
| 11 | 2023 | 8 | |
| 12 | 2023 | 3 | |
| 13 | 2023 | 16 | |
| 14 | 2023 | 1 | |
| 15 | 2022 | 47 | |
| 16 | 2021 | 23 | |
| 17 | 2021 | 8 | |
| 18 | 2017 | 1 | |
| 19 | Potential Predictive Value of TP53 and KRAS Mutation Status for Response to PD-1 Blockade Immunotherapy in Lung Adenocarcinomabreakdown → | 2016 | 741 |
| 20 | 2014 | 135 |
About Zhi Xie
Zhi Xie is a scholar working on Pharmacology, Molecular Biology and Oncology, having authored 376 papers that have together received 10.6k indexed citations. Recurring topics across this work include Gut microbiota and health (43 papers), Lung Cancer Treatments and Mutations (38 papers), RNA modifications and cancer (23 papers), RNA and protein synthesis mechanisms (21 papers), Metabolomics and Mass Spectrometry Studies (18 papers), Cancer Immunotherapy and Biomarkers (17 papers), Ginseng Biological Effects and Applications (16 papers) and Cancer Genomics and Diagnostics (15 papers). The work is most often cited by research in Oncology (2.5k citations), Cancer Research (1.2k citations) and Molecular Biology (5.3k citations). Zhi Xie has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Yi‐Long Wu, Xu‐Chao Zhang, Qing Zhou, Jian Su, Wen‐Zhao Zhong, Qiongfeng Liao, Jin‐Ji Yang, Qiongfeng Liao, Hai‐Yan Tu and Zhong‐Yi Dong. Their work appears in journals such as Cell, Nucleic Acids Research and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.